Free Trial

Hims & Hers Health Q2 2024 Earnings Report

Hims & Hers Health logo
$29.70 +1.86 (+6.66%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Hims & Hers Health EPS Results

Actual EPS
$0.06
Consensus EPS
$0.04
Beat/Miss
Beat by +$0.02
One Year Ago EPS
-$0.03

Hims & Hers Health Revenue Results

Actual Revenue
$315.65 million
Expected Revenue
$302.43 million
Beat/Miss
Beat by +$13.22 million
YoY Revenue Growth
+51.80%

Hims & Hers Health Announcement Details

Quarter
Q2 2024
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Hims & Hers Health Earnings Headlines

Hims & Hers: Ready To Outperform Further
Do this Before Elon’s Reveal on January 29th
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
Hims & Hers Health (NYSE:HIMS) Sees Large Volume Increase - What's Next?
Hims & Hers falls -6.5%
See More Hims & Hers Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hims & Hers Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hims & Hers Health and other key companies, straight to your email.

About Hims & Hers Health

Hims & Hers Health (NYSE:HIMS) operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

View Hims & Hers Health Profile

More Earnings Resources from MarketBeat